Calithera Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q3 2013 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Calithera Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2013 to Q4 2022.
  • Calithera Biosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$7.35M, a 89.4% increase year-over-year.
  • Calithera Biosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$42.1M, a 63.6% increase year-over-year.
  • Calithera Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$42.1M, a 63.6% increase from 2021.
  • Calithera Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$115M, a 26.3% decline from 2020.
  • Calithera Biosciences, Inc. annual Operating Income (Loss) for 2020 was -$91.4M, a 1.62% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$42.1M -$7.35M +$61.9M +89.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$104M -$9.53M +$1.62M +14.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$106M -$11.4M +$2.93M +20.5% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-16
Q1 2022 -$108M -$13.8M +$6.94M +33.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$115M -$69.2M -$46.5M -205% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$68.9M -$11.2M +$11.8M +51.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$80.6M -$14.3M +$6.45M +31.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$87.1M -$20.8M +$4.3M +17.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$91.4M -$22.7M -$210K -0.94% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-31
Q3 2020 -$91.2M -$22.9M -$1.77M -8.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$89.4M -$20.8M +$4.16M +16.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$93.6M -$25.1M -$668K -2.74% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$92.9M -$22.5M -$2.23M -11% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 -$90.7M -$21.1M -$1.62M -8.31% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$89M -$24.9M -$21.2M -566% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$67.9M -$24.4M -$10.6M -76.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$57.3M -$20.2M -$8.68M -75.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-16
Q3 2018 -$48.6M -$19.5M -$12.9M -193% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$35.7M -$3.74M +$2M +34.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$37.7M -$13.8M -$8.06M -140% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$29.7M -$11.5M -$1.94M -20.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 -$27.7M -$6.65M +$1.98M +22.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$29.7M -$5.74M +$4.71M +45.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$34.4M -$5.76M +$3.9M +40.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$38.3M -$9.6M -$1.48M -18.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$36.9M -$8.63M +$318K +3.55% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$37.2M -$10.4M -$2.57M -32.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$34.6M -$9.66M -$1.79M -22.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$32.8M -$8.13M -$1.29M -18.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$31.5M -$8.95M -$3.71M -70.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.8M -$7.87M -$2.38M -43.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$25.4M -$7.87M -$3.72M -89.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$21.7M -$6.84M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$5.24M -$1.92M -58% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$5.49M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$4.15M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$3.32M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.